Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Mereo BioPharma News
MREO
MEREO BIOPHARMA GROUP PLC
3.59
+4.06%
MREO
MEREO BIOPHARMA GROUP PLC
3.59
+4.06%
Articles
Latest stories
Ultragenyx and Mereo BioPharma Report 67% Reduction in Fractures with Setrusumab in Osteogenesis Imperfecta
Authors
11
22 days
Economics
Business
Ultragenyx and Mereo BioPharma Present Positive Phase 2 Data for Setrusumab, Reducing Fracture Rates in Osteogenesis Imperfecta
Authors
6
22 days
Economics
Business
Sanofi to Acquire Inhibrx for $30/Share in Cash, Plus $5 CVR and 0.25 Shares in New Company, Totaling $2.2B
Authors
4
5 months
Bio
Science
Previous
Next